HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan

  • Scheme Category:  
  • Equity Scheme >  
  • Sectoral/Thematic Funds
NAV: ₹ 21.543 ↓ -0.11%
[as on 28 July, 2026]

NAV chart

SMA (Simple Moving Average)

  • 50 SMA
  • 100 SMA
  • 200 SMA
  • 400 SMA

Returns

CAGR returns till date

CAGR returns of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan and its peers as on 28 July, 2026
NameYTD1D1W1M3M1Y3Y5Y7Y10Y
HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan 22.04% -0.11% -0.97% 3.81% 14.81% 19.02%----
SBI CONSUMPTION OPPORTUNITIES FUND - DIRECT PLAN - GROWTH -5.08% -0.18% 0.02% 1.4% -0.48% -4.23% 7.93% 14.09% 16.58% 14%
SBI ESG Exclusionary Strategy Fund - Direct Plan -Growth -3.34% 0.2% -0.75% 0.23% 2.55% 1.78% 10.23% 10.49% 13.4% 12.03%
SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH 20.9% 0.01% -0.52% 4.64% 16.11% 16.21% 23.8% 18.34% 25.76% 14.63%
SBI INFRASTRUCTURE FUND - DIRECT PLAN - GROWTH 2.57% -0.62% -2.13% -1.38% -0.52% 5.54% 16.41% 18.11% 19.75% 15.23%
SBI PSU Fund - DIRECT PLAN - GROWTH 0.53% -0.88% -1.71% -1.85% -6.68% 9.17% 23.84% 24.3% 20% 14.69%

Discrete returns (yearly)

Year2016201720182019202020212022202320242025
Returns-------- 52.37% 1.73%

Discrete returns (monthly)

MonthSep 2025Oct 2025Nov 2025Dec 2025Jan 2026Feb 2026Mar 2026Apr 2026May 2026Jun 2026
Returns -1.45% 2.16% 1.22% -1.38% -4.65% 6.99% -4.36% 7.84% 5.11% 6.59%

Returns from spefic dates

DescriptionCAGR returns from 26 Sep 2024 (Nifty 50 2024 high)
Returns 16.7%

Portfolio

Asset allocation

EquityDebtRealestateCommoditiesCash & Equivalents
98.52% 0.00% (Arbitrage: 0.00%) 0.00% 0.00% 1.48%

Equity

NameSymbol / ISINSectorWeight %
Sun Pharmaceutical Industries Ltd.SUNPHARMA (INE044A01036)Pharmaceuticals & Biotechnology10.20%
Divis Laboratories Ltd.DIVISLAB (INE361B01024)Pharmaceuticals & Biotechnology8.20%
Glenmark Pharmaceuticals Ltd.GLENMARK (INE935A01035)Pharmaceuticals & Biotechnology6.78%
Lupin Ltd.LUPIN (INE326A01037)Pharmaceuticals & Biotechnology6.65%
Alkem Laboratories Ltd.ALKEM (INE540L01014)Pharmaceuticals & Biotechnology5.99%
Max Healthcare Institute LimitedMAXHEALTH (INE027H01010)Healthcare Services5.96%
Aster DM Healthcare LimitedASTERDM (INE914M01019)Healthcare Services5.70%
Ipca Laboratories Ltd.IPCALAB (INE571A01038)Pharmaceuticals & Biotechnology5.16%
Acutaas Chemicals LimitedACUTAAS (INE00FF01025)Pharmaceuticals & Biotechnology4.39%
Anthem Biosciences LimitedANTHEM (INE0CZ201020)Pharmaceuticals & Biotechnology4.29%
Fortis Healthcare LimitedFORTIS (INE061F01013)Healthcare Services3.49%
Krishna Institute Of Medical Sciences LimitedKIMS (INE967H01025)Healthcare Services3.10%
Laurus Labs Ltd.LAURUSLABS (INE947Q01028)Pharmaceuticals & Biotechnology2.76%
Metropolis Healthcare Ltd.METROPOLIS (INE112L01020)Healthcare Services2.37%
Torrent Pharmaceuticals Ltd.TORNTPHARM (INE685A01028)Pharmaceuticals & Biotechnology2.34%
Eris Lifesciences LtdERIS (INE406M01024)Pharmaceuticals & Biotechnology2.24%
Vijaya Diagnostic Centre LimitedVIJAYA (INE043W01024)Healthcare Services2.13%
Sai Life Sciences LimitedSAILIFE (INE570L01029)Pharmaceuticals & Biotechnology2.09%
Shilpa Medicare LtdSHILPAMED (INE790G01031)Pharmaceuticals & Biotechnology1.91%
Global Health LimitedMEDANTA (INE474Q01031)Healthcare Services1.88%
Dr. Lal Path Labs LtdLALPATHLAB (INE600L01024)Healthcare Services1.57%
Neuland Laboratories LimitedNEULANDLAB (INE794A01010)Pharmaceuticals & Biotechnology1.54%
Wockhardt Ltd.WOCKPHARMA (INE049B01025)Pharmaceuticals & Biotechnology1.54%
Jubilant Pharmova LimitedJUBLPHARMA (INE700A01033)Pharmaceuticals & Biotechnology1.31%
Thyrocare Technologies Ltd.THYROCARE (INE594H01019)Healthcare Services1.27%
Rubicon Research LimitedRUBICON (INE506V01022)Pharmaceuticals & Biotechnology1.24%
Gland Pharma Ltd.GLAND (INE068V01023)Pharmaceuticals & Biotechnology1.07%
BAJAJ HEALTHCARE LIMITEDBAJAJHCARE (INE411U01027)Pharmaceuticals & Biotechnology0.83%
Laxmi Dental LimitedLAXMIDENTL (INE0WO601020)Healthcare Equipment & Supplies0.52%
Portfolio data is as on date 31 March, 2026

NAV history

HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan - 30 days NAV (Net asset value) history

DateNAV% change
28 July, 202621.543 -0.11%
27 July, 202621.566 1.47%
24 July, 202621.253 -0.22%
23 July, 202621.3 -0.68%
22 July, 202621.446 -1.42%
21 July, 202621.755 0.17%
20 July, 202621.718 0.97%
17 July, 202621.51 -0.87%
16 July, 202621.699 0.14%
15 July, 202621.669 0.83%
14 July, 202621.49 0.6%
13 July, 202621.361 0.03%
10 July, 202621.354 0.19%
9 July, 202621.313 1.52%
8 July, 202620.994 -1.07%
7 July, 202621.221 -0.79%
6 July, 202621.389 -0.09%
3 July, 202621.409 0.91%
2 July, 202621.216 0.87%
1 July, 202621.034 -0.21%
30 June, 202621.079 0.74%
29 June, 202620.924 0.82%
25 June, 202620.753 -0.25%
24 June, 202620.806 0.08%
23 June, 202620.789 0.65%
22 June, 202620.655 0.19%
19 June, 202620.615 0.98%
18 June, 202620.414 1.06%
17 June, 202620.199 0.23%
16 June, 202620.152

FAQ (Frequently asked questions)

  • What is latest/current NAV/price of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan?
    The latest NAV of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan is 21.543 as on 28 July, 2026.
  • What are YTD (year to date) returns of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan?
    The YTD (year to date) returns of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan are 22.04% as on 28 July, 2026.
  • What are 1 year returns of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan?
    The 1 year returns of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan are 19.02% as on 28 July, 2026.